Skip to main content
. 2022 Sep 21;23:199. doi: 10.1186/s13059-022-02770-3

Fig. 1.

Fig. 1

A schematic representation of the overall genomic safe harbor identification strategy. a Selection of common pMEIs from healthy individuals with AF > 0.1. b Removing pMEIs significantly associated with gene expression (FDR < 0.1 in eQTL mapping). c Removing pMEIs showing spatial proximity with oncogenes, tumor suppressor genes, and dosage-sensitive genes based on TADs and chromatin interaction mapping. d Removing pMEIs overlapping repressive chromatin regions